Skip to main content
Clinical Trials/NCT01607931
NCT01607931CompletedNot Applicable

The Effects of Acute Exercise on Glucose Kinetics, Beta-cell Function and the Incretin Effect in Subjects Representative of the Whole Glucose Tolerance Continuum

Rigshospitalet, Denmark1 site in 1 country12 target enrollmentStarted: January 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
12
Locations
1
Primary Endpoint
Glucose tolerance

Study Overview

Brief Summary

Human volunteers will be stratified by oral glucose tolerance status: normal glucose tolerant, impaired glucose tolerant, and type 2 diabetic. All subjects will undergo 4 experimental trials: [1] an oral glucose tolerance test (OGTT) combined with infused and ingested stable isotopes of glucose to assess glucose kinetics. [2] a 1 hour bout of cycling exercise at 50% of maximum power output, immediately followed by the same OGTT combined with stable isotope glucose tracers used in trial 1. [3] an isoglycemic clamp to match the plasma glucose profile measured in trial 1. [4] a 1 hour bout of cycling exercise at 50% of maximum power output, immediately followed by an isoglycemic clamp to match the plasma glucose profile measured in trial 2.

Exercise-induced changes in oral glucose tolerance, glucose kinetics, insulin and glucagon secretion, and the incretin effect will be examined. The exercise responses will be compared between the subjects groups of different glucose tolerance status.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •age 18-60 years
  • •BMI 18-35 kg/m2

Exclusion Criteria

  • •insulin dependency
  • •pregnancy
  • •presence or history of chronic cardiovascular, pulmonary, hepatic, renal, or hematological disease, or cancer
  • •contraindication to physical activity as assessed by ECG

Arms & Interventions

Resting Trial

No Intervention

a 1 hour period of rest immediately prior to OGTT or isoglycemic clamp

Exercise Trial

Experimental

a 1 hour cycling exercise bout immediately prior to the OGTT or isoglycemic clamp

Intervention: Exercise (Behavioral)

Outcomes

Primary Outcomes

Glucose tolerance

Time Frame: Plasma glucose will be measured at 10 minute intervals during the OGTT (3 hours) immediately following the period of rest or exercise

Incretin effect

Time Frame: Plasma insulin and C-peptide will be measured at 10 minute intervals during the OGTT (3 hours) and isoglycemic clamp (3 hours) immediately following the period of rest or exercise

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Thomas Solomon

Senior Researcher

Rigshospitalet, Denmark

Study Sites (1)

Loading locations...

Similar Trials

Exercise, Glucose Kinetics, and the... | Clinical Trial